| | 216974-75-3 Basic information More.. |
| Product Name: | Bevacizumab | | Synonyms: | BevacizuMab [USAN:INN];Anti-vegf monoclonal antibody;Bevacizumab;Immunoglobulin G1, anti-(human vascular endothelial growth factor) (human-mouse monoclonal rhumab-vegf gamma1-chain), disulfide with human-mouse monoclonal rhumab-vegf light chain, dimer;Rhumab-vegf;Unii-2S9zzm9Q9v;Avastatin;Bevacituzumab | | CAS: | 216974-75-3 | | MF: | C6638H10160N1720O2108S44 | | MW: | 0 | | EINECS: | 200-160-3 | | Mol File: | Mol File |  |
- Avastin
-
- 2026-08-28
- CAS:216974-75-3
- Purity: 0.99
- Bevacizumab
-
- 2026-08-28
- CAS:216974-75-3
- Min. Order: 1G
- Purity: 98%min
- Supply Ability: 30kg/month
- Bevacizumab
-
- $129.00
- 2026-08-20
- CAS:216974-75-3
- Purity: 98.00%
- Supply Ability: 10g
|
|
216974-75-3
Recommend Suppliers |
|